Sai Life Sciences
Sai Life Sciences, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1999, the company has established itself as a leading Contract Research and Manufacturing Services (CRAMS) provider, catering to global clients in drug discovery, development, and manufacturing. With a strong presence in key operational regions including North America and Europe, Sai Life Sciences offers a comprehensive range of services, from custom synthesis to formulation development. The company is recognised for its commitment to quality and innovation, which has earned it a solid market position and numerous accolades within the industry. Sai Life Sciences continues to drive advancements in life sciences, making significant contributions to the development of new therapeutics.
DitchCarbon Score
How does Sai Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sai Life Sciences's score of 28 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sai Life Sciences's reported carbon emissions
In 2023, Sai Life Sciences reported carbon emissions of approximately 12,610,200 kg CO2e for Scope 1 and about 17,536,600 kg CO2e for Scope 2. Notably, the company also recorded a negative Scope 3 emission of -4,050,000 kg CO2e, indicating a reduction in emissions from business travel, employee commuting, and transportation activities. Over the years, Sai Life Sciences has demonstrated a commitment to reducing its carbon footprint. In 2020, the company reported a significant increase in emissions, with Scope 1 at 14,682,000 kg CO2e and Scope 2 at 20,320,000 kg CO2e. However, by 2021, emissions were reduced to 12,533,820 kg CO2e for Scope 1 and 16,323,790 kg CO2e for Scope 2, showcasing a proactive approach to sustainability. Sai Life Sciences has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively engaged in initiatives to lower its emissions and improve sustainability practices within the pharmaceuticals, biotechnology, and life sciences sector. As of June 2023, they have not committed to a net-zero target but remain focused on reducing their carbon emissions in the coming years.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 498,000 | 000,000 | 000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | -0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sai Life Sciences is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
